(ENSG) The Ensign - Ratings and Ratios

The Ensign Group, Inc. is a healthcare services provider operating in the skilled nursing, senior living, and rehabilitative sectors. With a presence in 16 states across the US, the company offers a range of services, including short-term and long-term nursing care, specialty care, and ancillary services such as digital x-ray and dialysis. The companys business model is diversified across two segments: Skilled Services, which provides patient care, and Standard Bearer, which leases post-acute care properties to healthcare operators.

Ensign Groups operational footprint spans Alabama, Alaska, Arizona, Colorado, Idaho, Iowa, Kansas, Oregon, Nebraska, Nevada, South Carolina, Tennessee, Texas, Utah, Washington, and Wisconsin, with its headquarters located in San Juan Capistrano, California. The companys history dates back to 1999, and it has since grown to become a significant player in the healthcare facilities sector. For more information, you can visit their website at https://ensigngroup.net.

Analyzing the companys technical data, we observe that the stock price is currently at $152.38, with a 20-day SMA of $146.86, indicating a bullish trend. The 50-day and 200-day SMAs are at $135.97 and $139.86, respectively, further supporting the positive momentum. With an ATR of 3.26, representing a 2.14% daily volatility, the stock has shown a relatively stable price movement. Considering the 52-week high and low prices of $156.76 and $118.60, respectively, the current price is near the upper end of the range, suggesting a potential for consolidation or a slight pullback.

From a fundamental perspective, Ensign Groups market capitalization stands at $8.48 billion, with a P/E ratio of 27.26 and a forward P/E of 22.94. The companys return on equity is 17.27%, indicating a relatively strong profitability. Using these metrics, we can forecast that ENSG may continue to experience growth, driven by its diversified business model and expanding operational footprint. Based on the technical and fundamental data, a potential forecast could be that the stock price may reach $165 in the next 6-12 months, representing a 8-10% upside from current levels, driven by the companys continued growth and stability in the healthcare facilities sector.